We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AbbVie Settles Last Humira Suit, Protects Monopoly Until 2023
AbbVie Settles Last Humira Suit, Protects Monopoly Until 2023
AbbVie has settled its lawsuit with Boehringer Ingelheim, the last domino to fall in an all-out patent war that will protect AbbVie’s mega-blockbuster Humira until 2023.